Sung Lee | Vice President of Investor Relations |
Daniel O'Day | Chairman & Chief Executive Officer |
Robin Washington | Executive Vice President & Chief Financial Officer |
Laura Hamill | Executive Vice President, Worldwide Commercial Operations |
John McHutchison | Chief Scientific Officer & Head of Research & Development |
Geoffrey Meacham | Barclays |
Brian Abrahams | RBC Capital Markets |
Geoffrey Porges | SVB Leerink |
Michael Yee | Jeffries |
Carter Gould | UBS |
Ying Huang | Bank of America Merrill Lynch |
Umer Raffat | Evercore |
Phil Nadeau | Cowen and Company |
Cory Kasimov | JPMorgan |
Ronny Gal | Bernstein |
Ladies and gentlemen, thank you for standing by, and welcome to the Gilead Sciences' First Quarter 2019 Earnings Conference Call. My name is Jonathan and I will be your conference operator today. At this time, all participants are in a listen-only mode. And as a reminder, this conference call is being recorded. I would now like to turn the call over to Sung Lee, Vice President of Investor Relations.